Membrane localization of all class I PI 3‐kinase isoforms suppresses c‐Myc‐induced apoptosis in Rat1 fibroblasts via Akt

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.20479PMID 15838873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents.

  2003cited by this paper
• c-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner

  2003cited by this paper
• Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ

  2003cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Synthesis and function of 3-phosphorylated inositol lipids.

  2001influential reference
• Phosphoinositide 3-kinases and the regulation of vesicular trafficking.

  2000cited by this paper
• PI3-kinase inhibition: a target for drug development?

  2000cited by this paper
• Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.

  2000cited by this paper
• Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.

  2000influential reference
• NF-κB is a target of AKT in anti-apoptotic PDGF signalling

  1999cited by this paper
• Intracellular Movement of Green Fluorescent Protein–Tagged Phosphatidylinositol 3-Kinase in Response to Growth Factor Receptor Signaling

  1999cited by this paper
• Membrane-targeted Phosphatidylinositol 3-Kinase Mimics Insulin Actions and Induces a State of Cellular Insulin Resistance*

  1999cited by this paper
• Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

  1999cited by this paper
• Retinoic acid induces selective expression of phosphoinositide 3-kinase gamma in myelomonocytic U937 cells.

  1999cited by this paper
• c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release.

  1999cited by this paper
• NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

  1999cited by this paper
• Phosphoinositide kinases.

  1998cited by this paper
• Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis

  1998cited by this paper
• Regulation of cell death protease caspase-9 by phosphorylation.

  1998influential reference
• Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB

  1997cited by this paper
• A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997influential reference
• Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway

  1997cited by this paper
• R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways.

  1997cited by this paper
• Linkage of G Protein-Coupled Receptors to the MAPK Signaling Pathway Through PI 3-Kinase γ

  1997cited by this paper
• Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase.

  1996cited by this paper
• Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways

  1996cited by this paper
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.

  1995cited by this paper
• c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.

  1994cited by this paper
• A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits.

  1994cited by this paper
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper

• Lysimachia christinae Hance as an anticancer agent against breast cancer cells

  2020cites this paper
• UNRAVELINGTHE MOLECULAR MECHANISM BEHIND METABOLIC REPROGRAMMING CAUSED BY ALTERATIONS OF THE ENZYME PI3-KINASE

  2019cites this paper
• Vasculogenic mimicry and tumor metastasis.

  2016cites this paper
• The effect of PI 3 K inhibitor LY 294002 and gemcitabine hydrochloride combined with ionizing radiation on the formation of vasculogenic mimicry of Panc-1 cells in vitro and in vivo

  2016influential citation
• The role of PI3K and ERBB family gene mutations and other abnormalities in resistance to HER2-targeted therapies in HER2-positive breast cancer

  2016cites this paper
• Introduction Vasculogenic mimicry and tumor metastasis

  2016cites this paper
• The effect of PI3K inhibitor LY294002 and gemcitabine hydrochloride combined with ionizing radiation on the formation of vasculogenic mimicry of Panc-1 cells in vitro and in vivo.

  2016cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1092 Regulation of Platelet-Derived Growth Factor Receptor Signaling and its Targeting in Cancer Therapy

  2015cites this paper
• Advanced research on vasculogenic mimicry in cancer

  2015cites this paper
• Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers

  2015cites this paper
• High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer

  2015cites this paper
• Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway

  2014cites this paper
• Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis

  2014cites this paper
• The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models

  2014cites this paper
• Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.

  2013cites this paper
• Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era

  2012cites this paper
• Phosphoinositide 3-kinases in health and disease.

  2012cites this paper
• Gene Amplification in Ovarian Carcinomas: Lessons from Selected Amplified Gene Families

  2012cites this paper
• Present and future of PI3K pathway inhibition in cancer: perspectives and limitations.

  2011cites this paper
• The PKB/AKT pathway in cancer.

  2010cites this paper
• Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models

  2010cites this paper
• Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.

  2010cites this paper
• Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival

  2010cites this paper
• Mouse models to decipher the PI3K signaling network in human cancer.

  2009cites this paper
• Inhibiting PI3K as a therapeutic strategy against cancer

  2009cites this paper
• Development of techological platforms for the identification of novel cellular modulators of FOXO activity

  2009influential citation
• In vivo expression of signaling proteins in reconstituted NK cells.

  2009cites this paper
• A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling

  2008cites this paper
• The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

  2008cites this paper
• Genetic modelling of the PTEN/AKT pathway in cancer research

  2008cites this paper
• Chemical Genetic Analysis of FOXO Nuclear–Cytoplasmic Shuttling by Using Image‐Based Cell Screening

  2008cites this paper
• Investigating the isoform-specific role of phosphoinositide 3- kinase p110delta

  2008cites this paper
• In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.

  2007cites this paper
• MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation.

  2007cites this paper
• PTEN, more than the AKT pathway.

  2007cites this paper
• Cross-talk between IGF-I and TGF-β signaling pathways

  2006cites this paper
• Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

  2006cites this paper
• The Oscar-worthy role of Myc in apoptosis.

  2006cites this paper
• Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase

  2006cites this paper
• Mutations in PIK3CA are infrequent in neuroblastoma

  2006cites this paper
• Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria

  2005cites this paper